Divis Net Receivables from 2010 to 2025

DIVISLAB   6,132  32.00  0.52%   
Divis Laboratories' Net Receivables is increasing over the years with slightly volatile fluctuation. Overall, Net Receivables is expected to go to about 31.3 B this year. From 2010 to 2025 Divis Laboratories Net Receivables quarterly data regression line had arithmetic mean of  12,189,003,625 and r-squared of  0.73. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
29.8 B
Current Value
31.3 B
Quarterly Volatility
10.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Divis Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Divis Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 B, Interest Expense of 25.6 M or Total Revenue of 98.3 B, as well as many indicators such as . Divis financial statements analysis is a perfect complement when working with Divis Laboratories Valuation or Volatility modules.
  
This module can also supplement various Divis Laboratories Technical models . Check out the analysis of Divis Laboratories Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Divis Stock

Divis Laboratories financial ratios help investors to determine whether Divis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Divis with respect to the benefits of owning Divis Laboratories security.